AcuNetx, Inc. Announces New Executive Management for VisioNetx
Torrance, California, July 19, 2007
TORRANCE, Calif. - AcuNetx (OTCBB:ANTX), a leading developer
and producer of diagnostic, analytical and therapeutic tools, announced
today that it has appointed three new executives to lead its majority-owned
subsidiary, VisioNetx, Inc. Based in Boulder, Colorado, VisioNetx is the
developer and producer of a series of proprietary ocular scanning
technologies used to determine fitness for duty through impairment testing.
The three new executives are David Hunter, President and CEO; Collis
Woodward, Vice President and CFO; and Douglas MacCarthy, Vice President and
COO.
Mr. Hunter has served in leadership and executive management positions in
both the public and private sectors. He used his knowledge of the public
sector to lead the establishment of BI Incorporated as the worldwide,
dominant provider of electronic home arrest systems and services to 2,500
local and state governments in the United States and eight governments
internationally. Under Mr. Hunter’s leadership, BI grew from a small
entrepreneurial company to the powerhouse of the industry it created with
nearly $100 million in annual revenues and over 1,200 employees. The company
invented and patented technology-based systems and invented services based
upon unique, proprietary, therapeutic models that continue to be standards
in the “corrections” market across the federal, state and local governments
of this country.
"
Prior to joining VisioNetx, Inc., Mr. Woodward served as CFO for encryptX
Corporation, a security software company, and prior to that served as CFO of
a venture capital-backed internet services company. He was a founder, CFO
and Director of Acculabs, Inc., a network of environmental labs that
acquired 7 laboratories specializing in water testing. Prior to that he was
a founder and Director of Westerly Partners, an investment banking firm
serving small private and public companies in their financing and merger and
acquisition needs. He served as CEO of UVP, Inc., an international
manufacturer and distributor of ultraviolet light products and DNA
sequencing software. There he successfully returned the company to
profitability and improved operational performances. He spent seven years
with Gish Biomedical, Inc., a public medical device company, as CFO and
later COO. He assisted in the startup of operations, implementation of MRP
systems and controls, and directed an IPO and two acquisitions. He is a CPA
in California and was with the accounting firm of Arthur Young & Co. in
Orange County, California, for seven years. After receiving his BS in
Engineering at the University of California at Los Angeles he worked as an
electronics engineer for McDonnell Douglas Corporation and Hughes Aircraft
Company before embarking on his career in accounting and finance.
"
Speaking for AcuNetx, Ron Waldorf, President and CEO, commented, “This team
of seasoned executives brings a track record of success in building
businesses from the ground up. They have run both public and private
companies, taken companies public, taken companies private, built companies
organically and through acquisition, but most importantly learned the
significance of good organizational development to entrepreneurial success.”
About AcuNetx, Inc.
AcuNetx markets a diverse line of diagnostic, analytical and therapeutic
tools to audiologist, neurologists, otolaryngologists and physical
therapists, as well as hospitals, clinics and extended care facilities.
AcuNetx is headquartered in Torrance. For more information concerning AcuNetx and its subsidiaries, please visit www.acunetx.com
Safe Harbor for Forward-Looking Statements
This news release contains forward-looking statements that are made pursuant
to the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. While these statements are made to convey to the public the
company’s progress, business opportunities and growth prospects, readers are
cautioned that such forward-looking statements represent management’s
opinion. Whereas management believes such representations to be true and
accurate based on information and data available to the company at this
time, actual results may differ materially from those described. The
company’s operations and business prospects are always subject to risk and
uncertainties. Important factors that may cause actual results to differ are
set forth in the company’s periodic filings with the U.S. Securities and
Exchange Commission.
|